Last update 08 May 2025

CD154 gene therapy(University of California San Diego)

Overview

Basic Info

Drug Type
Gene therapy
Synonyms
CD154 gene therapy
+ [1]
Target
CD40L
Action
stimulants
Mechanism
CD40L stimulants(CD40 ligand stimulants)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
Originator Organization
University of California San DiegoUniversity of California San Diego
Active Organization-
Inactive Organization
University of California San DiegoUniversity of California San DiegoTragen Pharmaceuticals IncMemgen, Inc.Memgen, Inc.
+ [1]
License Organization-
Drug Highest PhaseDiscontinuedPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with CD154 gene therapy(University of California San Diego)
Login to view more data
100 Translational Medicine associated with CD154 gene therapy(University of California San Diego)
Login to view more data
100 Patents (Medical) associated with CD154 gene therapy(University of California San Diego)
Login to view more data
100 Deals associated with CD154 gene therapy(University of California San Diego)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Non-Hodgkin LymphomaPhase 2
United States
UCSD Moores Cancer Center
01 May 2007
Non-Hodgkin LymphomaPhase 2
United States
Memgen, Inc.Memgen, Inc.
01 May 2007
Chronic Lymphocytic LeukemiaPhase 2-
University of California San DiegoUniversity of California San Diego
-
Chronic Lymphocytic LeukemiaPhase 2-
Tragen Pharmaceuticals Inc
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free